Survival of mice with NC carcinoma is unchanged by drugs that are thought to inhibit thromboxane synthesis or increase prostacyclin formation.

Mice transplanted with NC carcinoma were treated with the thromboxane synthetase inhibitor dazmegrel (UK38485) or with nafazatrom (BAY G 6575), a compound that is reported to increase prostacyclin formation. Some experiments included the cytotoxic drugs methotrexate and melphalan. The tumours were e...

Descripción completa

Detalles Bibliográficos
Autores principales: Stamford, I. F., Melhuish, P. B., Carroll, M. A., Corrigan, C. J., Patel, S., Bennett, A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1986
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001530/
https://www.ncbi.nlm.nih.gov/pubmed/3755610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001530/
https://www.ncbi.nlm.nih.gov/pubmed/3755610

Ejemplares similares